Cephalon Thins FCA Off-Label Marketing, Kickback Suit
A Pennsylvania federal judge pared charges Wednesday from a False Claims Act case alleging pharmaceutical company Cephalon Inc. improperly promoted drugs for off-label uses, saying some state law claims could not...To view the full article, register now.
Already a subscriber? Click here to view full article